Derk-Jan A de Groot

8PUBLICATIONS
87CO-AUTHORS
Medical physicsPredictive and prognostic markersExercise physiologyCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 08, 2026
Tri-specific Humabody CB307 Targeting CD137, Prostate-specific Membrane Antigen, and Human Serum Albumin Whole-body Biodistribution Measured with 89Zr-CB307 PET.

|Nov 10, 2025
Early [18F]FDG PET/CT Response after a Single Dose of Anti-EGFR Therapy as a Predictive Biomarker for Treatment Benefit in Patients with Advanced Colorectal Cancer.

Sophie L Gerritse, Erik J van Helden, Anne I J Arens

|Jul 10, 2025
Impact of Physical Activity on Metastatic Cancer at Diagnosis and Mortality: Results from the Lifelines Cohort Study.

Mylena D Bos, Grigory Sidorenkov, Petra C Vinke

|Mar 17, 2025
A Phase I Dose Escalation and Cohort Expansion Study of CB307, a Trispecific Humabody against PSMA, CD137, and Albumin in Patients with PSMA-Positive Solid Tumors.

Johann S de Bono, Anja Williams, Ignacio Melero

|Sep 26, 2024
Molecular imaging supports the development of multispecific cancer antibodies.

Claudia A J van Winkel, Frank R Pierik, Adrienne H Brouwers

|Sep 26, 2024
Facts and Hopes for PET Imaging-Derived Immunotherapy Biomarkers.

Derk Jan A de Groot, Marjolijn N Lub-de Hooge, Tom van Meerten

Pageof 2

Frequent Collaborators

5 joint publications

Elisabeth Ge de Vries

3 joint publications

Marjolijn N Lub-de Hooge

3 joint publications

Adrienne H Brouwers

2 joint publications

Claudia Aj van Winkel